HOME >> BIOLOGY >> NEWS
Acorda Therapeutics receives L.W. Freeman Award for Scientific Research

Hawthorne, NY /Mesa, AZ November 13, 2002 - Acorda Therapeutics, a biotechnology company located in Hawthorne, NY, will receive the L.W. Freeman Award for Scientific Research tomorrow evening at the National Spinal Cord Injury Association (NSCIA) 2002 Annual Conference in Mesa, AZ.

This award is given annually for pioneering research on regeneration in spinal cord injury or disease and was established in memory of Dr. L. W. Freeman, who was one of the original members of the NSCIA Medical Advisory Committee. A scientist at Indiana University, Dr. Freeman was committed to research that advanced the knowledge of treatment for spinal cord injury. Dr. Freeman was a tireless researcher and teacher, and he served as a key advisor to the Association until his death in 1969.

Marcie Roth, Executive Director of the NSCIA, said, "The NSCIA recognizes the significant contribution that Acorda Therapeutics is making in scientific research that benefits the spinal cord injury community. Acorda's research platform encompasses a broad range of therapeutic targets ranging from regenerative therapies to therapies focused on improved function designed to improve the quality of life and overall health for persons living with a spinal cord injury."

Ron Cohen, M.D., Founder and CEO of Acorda Therapeutics, said, "Acorda is the first company to focus on the development of therapies to restore function in people with SCI. We are proud to be working with the NSCIA to achieve this and are honored to accept this award. Our lead product, Fampridine-SR, entered Phase 3 clinical trials for chronic SCI this year. This is the first time a therapy for improving function in chronic SCI has reached that milestone. Our relationship with the NSCIA continues to be an important catalyst in helping to move the research and education forward in SCI."

The awards ceremony will take place at The Sheraton Mesa Hotel and Convention Center at 6:00 pm on Thursday, November 14, 20
'"/>

Contact: Tierney Saccavino, Acorda
tsaccavino@acorda.com
914-347-4300
Porter Novelli
13-Nov-2002


Page: 1 2

Related biology news :

1. Acorda therapeutics receives NIH Phase 2 grant for central nervous system repair
2. Acorda Therapeutics acquires CeNeS neuregulin products
3. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
4. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
5. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
6. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
7. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
8. Medimmune and Critical Therapeutics to co-develop treatments for severe inflammatory diseases
9. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
10. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
11. Immerge BioTherapeutics announces identification of PERV receptor

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... GENOA, Italy , May 23, 2017  Hunova, the first robotic ... and trunk, has been officially launched in Genoa, Italy ... Europe and the USA . The ... launched on the market by the IIT spin-off Movendo Technology thanks to ... view the Multimedia News Release, please click: ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert in ... media edge server, the M820, which features the company,s hybrid codec ... provided by Tera Probe, Inc., will be showcased during the upcoming ... NAB show at the Las Vegas Convention ... Click ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... ... 2017 , ... The award-winning American Farmer television series will feature 3 Bar ... Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten billion ... continue to feed a growing nation. At the same time, many of our valuable ...
Breaking Biology Technology:
Cached News: